April 7, 2020 10:11am

Jumps +$0.85 or +24.7% to $4.27

PSTI plans to apply for initiation of multinational clinical trial for treatment of complications associated with COVID-19  

PSTI preliminary data from its compassionate use program, treated seven patients suffering from acute respiratory failure and inflammatory complications associated with COVID-19 with PSTI’s PLX cells, in three medical centers in Israel. 

  • All treated patients were in Intensive Care Units (ICU) on ventilators and suffered from Acute Respiratory Distress Syndrome (ARDS)